Summary
Aurobindo Pharma Ltd (Aurobindo Pharma) is a pharmaceutical company that develops, manufactures and exports generic pharmaceuticals and active pharmaceutical ingredients. Its business segments include active pharma ingredients (APIs), formulations, antibiotics, anti-retrovirals, anti- allergics, hivs, peptides, nutraceutical and aurozymes; spread across the globe. The company offers its services in the therapeutic areas of central vascular system, central nervous system, gastronenterology, allergology, cephalosporins, retrovirals and diabetics. Aurobindo Pharma also offers contract research and manufacturing services (CRAMS) across all the clinical stages of drug lifecycle. It carries out the largest research and development (R&D) facilities in India, developing intellectual property in the field of non-infringing processes. The company operates in countries including China, South Africa, Australia, Germany, Japan, the US, and the UK, among others. Aurobindo pharma is headquartered in Hyderabad, India.
Aurobindo Pharma Ltd (AUROPHARMA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Aurobindo Pharma Ltd, Medical Devices Deals, 2010 to YTD 2016 10
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Aurobindo Pharma Completes Acquisition Of Generics Operations Of Actavis In Western Europe For US$40.8 Million 13
Partnerships 15
Aurobindo Pharma to Form Joint Venture with Tergene Biotech 15
Celon Labs Forms Joint Venture with Aurobindo Pharma 16
Aurobindo Pharma Forms Joint Venture With DIODE 17
Licensing Agreements 18
Aurobindo Pharma To Enter Into Licensing Agreement With Pfizer 18
Aurobindo Pharma Enters Into Licensing And Supply Agreement With AstraZeneca 20
Equity Offering 21
Aurobindo Pharma Plans to Raise USD300 Million in Private Placement of Shares 21
Aurobindo Pharma Receives Board Approval for Private Placement of Shares for up to USD350 Million 22
Asset Transactions 24
Aurobindo Pharma Sells Manufacturing Facility In Tamilnadu 24
Acquisition 25
Sagent Pharma May Sell Itself 25
Eris Pharma Acquires Aurobindo Pharma Australia from Aurobindo Pharma 27
Aurobindo Pharma Acquires Natrol for USD132.5 Million 28
Aurobindo Pharma Acquires Hyacinths Pharma for up to USD3 Million 30
Aurobindo Pharma Acquires Remaining 25% Stake in Silicon Life Sciences from ABS Mercantiles 31
Aurobindo Pharma To Acquire Branded Formulations Marketing Company 32
Aurbindo Pharma Sells 50% Stake In Cephazone Pharma, Maker Of Cephalosporin Products 33
China National Pharma Completes Acquisition Of 80.5% Interest In Aurobindo (Datong) Bio Pharma 34
Aurobindo Pharma Ltd - Key Competitors 36
Key Employees 37
Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Aurobindo Pharma Ltd, Deals By Therapy Area, 2010 to YTD 2016 8
Aurobindo Pharma Ltd, Medical Devices Deals, 2010 to YTD 2016 10
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 11
Aurobindo Pharma Completes Acquisition Of Generics Operations Of Actavis In Western Europe For US$40.8 Million 13
Aurobindo Pharma to Form Joint Venture with Tergene Biotech 15
Celon Labs Forms Joint Venture with Aurobindo Pharma 16
Aurobindo Pharma Forms Joint Venture With DIODE 17
Aurobindo Pharma To Enter Into Licensing Agreement With Pfizer 18
Aurobindo Pharma Enters Into Licensing And Supply Agreement With AstraZeneca 20
Aurobindo Pharma Plans to Raise USD300 Million in Private Placement of Shares 21
Aurobindo Pharma Receives Board Approval for Private Placement of Shares for up to USD350 Million 22
Aurobindo Pharma Sells Manufacturing Facility In Tamilnadu 24
Sagent Pharma May Sell Itself 25
Eris Pharma Acquires Aurobindo Pharma Australia from Aurobindo Pharma 27
Aurobindo Pharma Acquires Natrol for USD132.5 Million 28
Aurobindo Pharma Acquires Hyacinths Pharma for up to USD3 Million 30
Aurobindo Pharma Acquires Remaining 25% Stake in Silicon Life Sciences from ABS Mercantiles 31
Aurobindo Pharma To Acquire Branded Formulations Marketing Company 32
Aurbindo Pharma Sells 50% Stake In Cephazone Pharma, Maker Of Cephalosporin Products 33
China National Pharma Completes Acquisition Of 80.5% Interest In Aurobindo (Datong) Bio Pharma 34
Aurobindo Pharma Ltd, Key Competitors 36
Aurobindo Pharma Ltd, Key Employees 37
Aurobindo Pharma Ltd, Other Locations 38
Aurobindo Pharma Ltd, Subsidiaries 38
List of Figures
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Aurobindo Pharma Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Aurobindo Pharma Ltd, Medical Devices Deals, 2010 to YTD 2016 10
